Speak once again about the relevance of preventionand there is no point in treating acute respiratory infections and flu, and specialists and ordinary citizens are well aware of the consequences that a “cold” can bring if it is not treated properly. Obviously, at such a representative forum, and this year more than two thousand specialists from 93 countries of the world took part in its work, they could not ignore such an important topic. A significant contribution to the forum was made by the Russian delegation, represented by two hundred specialists of various profiles.
One of the papers presented at the Forum andpublished in the journal The Cochrane Community «Cochrane review journal« Evidence-Based Child Health », prepared on the basis of the results of research conducted by specialists of Russian State Medical University, led by Professor of Faculty of Pediatrics, MD Tamara Kazyukovoy.
Research "Clinical and epidemiological assessmentthe effectiveness of Oscillococcinum in the framework of the family prevention of respiratory infections during the surge in respiratory morbidity in 2009-2010. " lasted 17 weeks (from November 1, 2009 to March 1, 2010), 376 people from 72 families took part in it. The main group consisted of 36 families (n = 164), all members of which took prophylactically Oscillococcinum 1 tube once a week. The second group also included 36 families (n = 162), whose members used any other means of preventing ARVI without a specific system, sometimes with the first symptoms of ARI.
The results presented by Tamara Kazyukovoy,It was remarkable. During the epidemic season in the main group was ill 21 (12.8%) patients, which was almost three times lower than in the second group, where 62 sick (38%) of a person. In addition, the study group was not registered a single case of flu, while in the second group in 7 cases (4.3%) were diagnosed with influenza A (N1H1) in 2009, revealed by laboratory tests. Here it should be noted that among the cases of influenza was not a single person vaccinated against influenza.
It was also noted that the drug allowedminimize the development of complications in case of illness and remained safe for prolonged use. In particular, there were no adverse reactions in children with lactase deficiency.
Results of the study showed clinicalOscillococcinum efficacy for the prevention of family incidence of influenza and other acute respiratory viral infections in the epidemiological season lifting respiratory disease. During the administration of the drug was not a single case of side effects or allergic reactions, although in 38.4% of cases the drug was combined with taking other drugs. Thus, it proved the safety of long-term use of the drug in patients aged 3.5 months. up to 76 years and the possibility of combination with other preparty.
“The findings of this observation are highpractical value for primary care physicians. We have received reliable confirmation of the effectiveness of collective systematic and targeted prevention. Based on the main parameters of preventive measures - the systematic nature, duration and feasibility of all family members from children to the elderly - the basic requirements for medicines for prevention become obvious.
it is very important for us, because Russia is not yetcaught neither the tradition of prevention of respiratory diseases, neither the principle of comprehensive treatment and chemotherapy are the basic treatment of the dominant means - emphasizes Tamara Kazyukova. It is known that many doctors in Europe today are beginning to pay attention to the fact that the use of chemically synthesized drugs is fraught with a lot of side effects, the development of resistance, etc., the expert said. The fact that the results of observation were in tune with the global trend, which gave us the confidence to implement them in practice. "